These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 5300283)

  • 41. [The role of intravenous infusion of antibacterial preparations in surgery for extensive fibrous-cavernous pulmonary tuberculosis].
    Batmanov NIa; Kanevskaia SS
    Probl Tuberk; 1969; 47(1):22-7. PubMed ID: 5380203
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
    Aspevik E
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment with secondary antitubercular agents].
    Ovreberg K
    Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856
    [No Abstract]   [Full Text] [Related]  

  • 46. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 47. [Experimental trials and clinical observations on the use of intravenous morphazinamide in chronic pulmonary tuberculosis].
    Di Perna A; Berti R; Cinotti D
    Minerva Med; 1965 Sep; 56(71):2872-8. PubMed ID: 4954934
    [No Abstract]   [Full Text] [Related]  

  • 48. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intravenous and topical use of morphazinamide in the pre- and post-operative treatment of pulmonary and pleural tuberculosis].
    Maggio L; Tabocchini W
    Minerva Med; 1965 Sep; 56(70):2797-809. PubMed ID: 5853905
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 51. Capreomycin-ethionamide as a retreatment regimen for pulmonary tuberculosis.
    Schless JM; Allison RF; Inglis RM; Topperman S; Trapp E
    Ann N Y Acad Sci; 1966 Apr; 135(2):1085-97. PubMed ID: 5328002
    [No Abstract]   [Full Text] [Related]  

  • 52. [Application of ethionamide aerosols in the treatment of pulmonary tuberculosis].
    Kulik NM
    Probl Tuberk; 1971; 49(4):68-9. PubMed ID: 5138430
    [No Abstract]   [Full Text] [Related]  

  • 53. [Problems of post-sanatorial antimycobacterial treatment].
    Corda M
    Minerva Med; 1965 Sep; 56(70):2827-31. PubMed ID: 5852641
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of resistant chronic tuberculosis. A new antitubercular agent: terizidone].
    Hammerli A; Gallindo IS
    Rev Bras Med; 1969 Nov; 26(11):684-8. PubMed ID: 5396432
    [No Abstract]   [Full Text] [Related]  

  • 55. [Introduction of antibacterial drugs into the pulmonary artery in the treatment of patients with extensive forms of tuberculosis].
    Kuziukovich PM; Shchukin MI
    Probl Tuberk; 1973; 51(1):27-30. PubMed ID: 4727154
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
    Takashima T; Danno K; Tamura Y; Nagai T; Matsumoto T; Han Y; Ano H; Yoshida H; Kawahara K; Tsuyuguchi I
    Kekkaku; 2006 Jun; 81(6):413-8. PubMed ID: 16838679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG; Maksimova NM
    Probl Tuberk; 1984 Jan; (1):45-9. PubMed ID: 6422459
    [No Abstract]   [Full Text] [Related]  

  • 59. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 60. Advice on treatment of drug-resistant tuberculosis.
    Peloquin CA; Berning SE
    Am J Health Syst Pharm; 1997 Mar; 54(6):700-1. PubMed ID: 9075505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.